Catalyst Pharmaceuticals Inc (NAS:CPRX)
$ 31.49 +0.0050 (+0.02%) Market Cap: 3.85 Bil Enterprise Value: 3.10 Bil PE Ratio: 18.10 PB Ratio: 3.80 GF Score: 70/100

Catalyst Pharmaceuticals Inc at Bank of America CNS Therapeutics Conference (Virtual) Transcript

Dec 08, 2025 / 05:35PM GMT
Release Date Price: $23.16 (-1.57%)
Operator

Ladies and gentlemen, the program is about to begin. At this time, it is my pleasure to turn the program over to your host, Jason Gerberry.

Jason Gerberry
Bank of America - Analyst

Good day everybody, and thanks for joining us at the VA, virtual CNS conference. My name is Jason Gerberry. I'm one of the Biotech Analysts here and I'm joined by [Pavin Patel], who's, one of my colleagues who helps, with Catalyst Pharma. Catalyst Pharma is our next company presenter and, Rich Daly, CEO.

So, Rich, thanks so much for, joining us and, giving us the latest update on Catalyst.

Richard Daly
Catalyst Pharmaceuticals Inc - President, Chief Executive Officer

Well, Jason, thanks for having us. We really appreciate it and I'm looking forward to the conversation, so thank you.

Questions & Answers

Jason Gerberry
Bank of America - Analyst

So maybe just starting with kind of the overarching. BD in licensing and that's obviously kind of core to what you do and building

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot